WGS

45.4607.68%
KA

Katherine A. Stueland

CEO & Director

Ms. Katherine A. Stueland is Chief Executive Officer and Director of GeneDx, Inc. Ms. Stueland was President & CEO of GeneDx, Inc. from June 2021. Ms. Stueland joined the GeneDx, Inc. in June 2021. Ms. Stueland serves as Chief Executive Officer at GeneDx Holdings Corp. (formerly known as Sema4 Holdings Corp.) from June 2021 and serves as its Director since May 2022 and had been its President from June 2021. She served as President and CEO of GeneDx, Inc. from June 2021. She served as Chief Commercial Officer at Invitae Corporation since October 2016 until June 18, 2021 and served as its Head of Communications and Investor Relations from January 2014 to October 2016. Prior to joining Invitae, Ms. Stueland was a Principal at Vivo Communications, a healthcare communications company, from January 2013 to December 2013. Ms. Stueland served as Head of Commercial, Communications and Investor Relations at Invitae Corporation since October 15, 2016 until October 2016. Ms. Stueland served as an Associate of WeissComm Partners, Inc. Ms. Stueland served as Vice President of Corporate Communications and Investor Relations at Dendreon Corp. from September 2009 to June 2012. Ms. Stueland joined WeissComm from TAP Pharmaceutical Products Inc., where she served as the Head of Public Affairs and was responsible for providing strategic counsel to the executive leadership team and managing product and marketing public relations for Prevacid for acid reflux and Lupron Depot for prostate cancer and other indications. She has particular expertise in crisis management, corporate reputation management and executive communications. Ms. Stueland played an integral role in supporting the launch and rapid growth of Prescott Medical Communications, a medical education and publications planning agency based in Chicago. She began her career at BSMG Medical and Healthcare Communications (now Weber Shandwick), supporting communications programs for a variety of healthcare clients. She also led the public affairs team at Takeda Abbott Pharmaceuticals (TAP) and worked with a variety of biotechnology and pharmaceutical companies on their communications strategies. Ms. Stueland serves as Member of Strategy Team at InVitae Corporation. Ms. Stueland also previously served on the board of the Rivkin Center. At Invitae, Ms. Stueland is responsible for communications, public relations, Investor Relations, advocacy and thought leader development. Ms. Stueland holds a B.S in English Literature from Miami University in Ohio in 1997.

Positions